Abstract：
Cognitive behavioral therapies have been identified as evidence-based treatments for anxiety-related disorders. However, data supporting the effectiveness of these treatments have been largely collected from participants with majoritized identities, potentially limiting the extent to which they can be considered \"evidence-based\" for clients from minoritized groups. The current review examined sociodemographic representation and quality of sociodemographic reporting in randomized controlled trials for anxiety-related disorders in the U.S. between 1993 and 2023. We conducted a systematic literature review of U.S.-based randomized controlled trials of cognitive behavioral therapies for anxiety-related disorders, extracted data on sociodemographic variables, and rated quality of reporting. Data from 55 eligible studies (N = 4492) indicated that white and female identities were overrepresented relative to the U.S. population, with variables like disability status, sexual orientation, and religious identification consistently ignored. In addition, quality of reporting was generally poor (mean = 3.6 out of 10), with many studies failing to account for demographic variables in their analyses or description of study limitations. Publication year, sample size, and NIH funding status did not significantly predict gender representation (% women), ethnoracial representation (% white), or quality of reporting. These findings underscore the importance of critically evaluating to whom \"evidence-based\" treatments apply and increasing diversity of clinical samples, to ensure that evidence-based treatments are inclusive. Recommendations for future research, clinical implications, and limitations are discussed.
摘要：
认知行为疗法已被确定为焦虑相关疾病的循证治疗。然而,支持这些治疗方法有效性的数据主要是从具有重要身份的参与者那里收集的，潜在地限制了他们可以被认为是“基于证据”的客户的程度。本综述研究了1993年至2023年美国焦虑相关疾病随机对照试验中的社会人口统计学代表和社会人口统计学报告质量。我们进行了一个系统的文献综述，以美国为基础的随机对照试验的认知行为疗法的焦虑相关障碍，提取社会人口统计学变量的数据，并对报告质量进行评级。来自55项符合条件的研究（N=4492）的数据表明，相对于美国人口，白人和女性身份的比例过高。有残疾状况等变量，性取向,和宗教认同一直被忽视。此外,报告质量普遍较差(平均值=10分之3.6)，许多研究在分析或描述研究局限性时未能考虑人口统计学变量。出版年,样本量,NIH的资助状况并没有显著预测性别代表性(%女性)，代表（%白色），或报告质量。这些发现强调了批判性评估“循证”治疗方法适用于谁以及增加临床样本多样性的重要性。以确保循证治疗具有包容性。对未来研究的建议，临床意义，并讨论了局限性。
